Frontiers Current Pharmacological Strategies for Duchenne

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

EMA starts review of Italfarmaco's Duchenne drug

Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases - eBioMedicine

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Frontiers Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks

Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

Duchenne muscular dystrophy - Wikipedia

Emerging therapies for Duchenne muscular dystrophy - The Lancet Neurology

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Frontiers Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia

Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy

Current management of Duchenne muscular dystrophy in the Middle East: expert report